Latvia vs Poland: Share of E. coli infections resistant to cephalosporins
Latvia
16.2%
in 2022
Poland
18.8%
in 2022
Latvia rank
34th
Poland rank
31st
Share of E. coli infections resistant to cephalosporins over time
- Latvia
- Poland
How they compare
Poland currently reports 18.8% against 16.2% in Latvia, a difference of 2.6%.
That makes Poland's figure about 1.2 times Latvia's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Latvia ahead.
Latvia ranks 34th and Poland ranks 31st of 46 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 18.8% | 17.4% | 1.4% | Latvia |
| 2020s | 22.8% | 18.4% | 4.4% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Latvia or Poland?
- Poland, at 18.8% against 16.2% in Latvia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Latvia and Poland?
- 2.6%, with Poland ahead.
- How many years of comparable data are there for Latvia and Poland?
- 6 years are reported by both, from 2017 to 2022.
- How do Latvia and Poland rank globally for share of e. coli infections resistant to cephalosporins?
- Latvia ranks 34th and Poland ranks 31st of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).